BioSpace News Archive

Allakos Inc. (the “Company” or “Allakos”) (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) for the treatment of eosinophil and mast cell-related diseases, today announced that Baird Radford has been appointed Chief Financial Officer.

Potential First-in-Class Therapy for a Subset of Gastric and Gastroesophageal Cancers That Overexpress Fibroblast Growth Factor Receptor 2 (FGFR2b) Designation is Supported by Results From the Phase 2 FIGHT Trial

SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of its 3D-printed WaveForm TO (TLIF Oblique) Interbody System.

The issues raised by Relief Therapeutics in its release dated April 19, 2021 have no bearing on NeuroRx’s ability or commitment to deliver a safe, effective, and stable lifesaving drug on a worldwide basis.

Brooks Automation, Inc. (Nasdaq: BRKS) will announce fiscal 2021 second quarter which ended on March 31, 2021 on Monday, May 10, 2021 after the market closes. The Company will host a conference call and live webcast to discuss its financial results on the same day, Monday, May 10, 2021 at 4:30 p.m. Eastern Time

Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company and manufacturer of SurgiMend Collagen Matrix, today issued the following statement regarding the U.S. FDA safety communication on the differences in complication rates between acellular dermal matrix (ADM) products used in implant-based breast reconstruction.

hear.com, the largest online provider of expert, medical-grade hearing care globally, today announced that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to the proposed initial public offering of the common shares of hear.com N.V.

AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”) , a national leader in providing patient-centric and technology-enabled chronic disease management solutions including home healthcare equipment, medical supplies to the home and related services in the United States, announced today that it will release its financial results for the first quarter ended March 31, 2021

MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company will release its financial results for the first quarter of 2021 after the market closes on Thursday, April 29, 2021.

Nanodropper, Inc., a medical device company offering a first-of-its-kind eyedrop bottle adaptor that reduces eyedrop size, recently completed a $1.4 million seed round.